AKT1 and serum lipopolysaccharide activity: In summary, we showed the therapeutic potential of BMSCs in ALF by repairing the intestinal epithelial barrier and preventing endotoxemia, and the PI3K/AKT/mTOR signaling pathway was involved in the intestinal differentiation of BMSCs.